{
    "Trade/Device Name(s)": [
        "IMDx C. difficile for Abbott m2000"
    ],
    "Submitter Information": "Intelligent Medical Devices, Inc.",
    "510(k) Number": "K132235",
    "Predicate Device Reference 510(k) Number(s)": [
        "K123355"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZN"
    ],
    "Summary Letter Date": "July 17, 2013",
    "Summary Letter Received Date": "July 18, 2013",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3130"
    ],
    "Regulation Name(s)": [
        "C. difficile Nucleic Acid Amplification Test Assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Clostridium difficile toxin A gene (tcdA)",
        "Clostridium difficile toxin B gene (icdB/tcdBv)"
    ],
    "Specimen Type(s)": [
        "Liquid stool",
        "Soft stool"
    ],
    "Specimen Container(s)": [
        "Unpreserved stool container",
        "Cary Blair transport medium"
    ],
    "Instrument(s)/Platform(s)": [
        "Abbott m2000 System",
        "Abbott m2000sp",
        "Abbott m2000rt"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Nucleic acid amplification"
    ],
    "Methodologies": [
        "PCR amplification",
        "Qualitative detection of nucleic acids"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for IMDx C. difficile for Abbott m2000 real-time PCR assay for qualitative detection of C. difficile toxin genes in stool specimens.",
    "Indications for Use Summary": "Qualitative detection of nucleic acids encoding C. difficile toxin A and B genes in human liquid or soft stool specimens from patients suspected of Clostridium difficile infection, as an aid in diagnosis, using the Abbott m2000 system.",
    "fda_folder": "Microbiology"
}